Tag: Immunosuppressants

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Immunosuppressants

Ankylosing Spondylitis Market Size to Hit USD 11.15 Billion - GlobeNewswire

Added to Collection on: 2025-08-21 13:53:46

Tags for this article:

Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Disease-modifying antirheumatic drugs
Biotechnology
Biopharmaceutical
Ankylosing spondylitis
Adalimumab
Etanercept
Biosimilar
Infliximab
Spondyloarthritis

Click the tags to see associated articles and topics

View Article Details
Biosimilars Market to Surpass US$ 171.79 Billion by 2033 - Exclusive Report by DataM Intelligence

Added to Collection on: 2025-08-22 15:13:23

Tags for this article:

Specialty drugs
Monoclonal antibodies
Orphan drugs
Immunosuppressants
TNF inhibitors
Biosimilar
Biopharmaceutical
Biocon
Adalimumab
Rituximab
Trastuzumab
Bevacizumab

Click the tags to see associated articles and topics

View Article Details
Accord BioPharma Announces Commercial Launch of IMULDOSA® (ustekinumab-srlf ... - JD Supra

Added to Collection on: 2025-08-26 17:19:32

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Autoimmune diseases
Disease-modifying antirheumatic drugs
Janssen Biotech
Ustekinumab
Psoriatic arthritis
Biosimilar
Psoriasis
Syringe
Accord BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
FDA to Waive Clinical Efficacy Studies for Monoclonal Antibody Biosimilars

Added to Collection on: 2025-09-02 20:28:54

Tags for this article:

Pharmaceutical industry
Specialty drugs
Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Biosimilar
Biopharmaceutical
Adalimumab
Sarfaraz K. Niazi
Generic drug
Food and Drug Administration
Association for Accessible Medicines

Click the tags to see associated articles and topics

View Article Details
Hansa Biopharma Presenting at the Pareto 16 Annual Healthcare Conference

Added to Collection on: 2025-09-15 15:16:53

Tags for this article:

Imlifidase
Immunosuppressants
SS Hansa
Cision
Lund
Sweden
Hansa Biopharma AB

Click the tags to see associated articles and topics

View Article Details
New Novartis data further support benefits of Kesimpta® in relapsing MS following switch ...

Added to Collection on: 2025-09-24 12:46:13

Tags for this article:

Ofatumumab
Multiple sclerosis
Autoimmune diseases
Immunosuppressants
Genmab
Research in multiple sclerosis
Fingolimod
Novartis
Progressive multifocal leukoencephalopathy
Barcelona
EAST HANOVER
Novartis AG
Spain

Click the tags to see associated articles and topics

View Article Details
Bristol touts its first pivotal celmod win | ApexOnco - Oncology Pipeline

Added to Collection on: 2025-09-24 19:52:28

Tags for this article:

Orphan drugs
Immunosuppressants
Aromatic amines
Phthalimides
Antineoplastic drugs
Lenalidomide
Dexamethasone
Daratumumab
Pomalidomide
Bortezomib
Carfilzomib
Multiple myeloma
Velcade
Bristol
Bristol-Myers Squibb
Revlimid

Click the tags to see associated articles and topics

View Article Details
Characteristics of patients who developed transient anti-adalimumab antibodies

Added to Collection on: 2025-09-24 18:45:32

Tags for this article:

Immunology
Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Biotechnology
Adalimumab
Autoimmunity
Rheumatology
Autoimmune disease

Click the tags to see associated articles and topics

View Article Details
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial ... - Cision News

Added to Collection on: 2025-09-24 21:42:04

Tags for this article:

Kidney diseases
Organ failure
Organ transplantation
Imlifidase
Immunosuppressants
Kidney transplantation
Kidney disease
Kidney failure
Chronic kidney disease
Kidney dialysis
Dorry Segev
Kidney Paired Donation

Click the tags to see associated articles and topics

View Article Details
Lupus Nephritis Market to Advance at a CAGR of 8.5% During the Forecast Period (2025-2034)

Added to Collection on: 2025-10-06 21:46:43

Tags for this article:

Kidney diseases
Autoimmune diseases
Immunosuppressants
Orphan drugs
Connective tissue diseases
Lupus nephritis
Lupus
Belimumab
Nephritis
Voclosporin
Kidney disease
Obinutuzumab
Germany
Italy
Anifrolumab
France
Japan
United States
United Kingdom
Spain

Click the tags to see associated articles and topics

View Article Details
Book a Demo